Chest
Malignant Pleural Effusion Treated by Tetracycline Sclerotherapy: A Comparison of Single vs Repeated Instillation
Section snippets
PATIENTS AND METHODS
Fifty patients with progressive dyspnea or chest discomfort secondary to malignant pleural effusion were entered into the study between June 1985, and January 1987. The primary malignancies responsible for the pleural effusions are listed in Table 1. Patients were alternately assigned to receive either a single instillation of tetracycline (group 1) or to have instillation of tetracycline on two consecutive days (group 2). The study was approved by the Committee on Human Research, and the
RESULTS
As can be seen from Table 2, there was a total of eight recurrent effusions in the 50 patients, but only four required retreatment. In the 25 group 1 patients who received one dose of tetracycline sclerotherapy, there were four recurrent effusions, three of which required additional treatment. Of the 25 group 2 patients, four had recurrent effusions, but only one was of sufficient size to produce symptoms and require retreatment. All recurrent symptomatic effusions were treated with
DISCUSSION
Malignant pleural effusion occurs in as many as 50 percent of patients with cancer at some point in the course of their disease.2 Symptomatic effusions require treatment for relief of respiratory compromise. The ideal form of treatment should result in little morbidity, have a low cost, provide predictable results, and be easy to administer.
Numerous treatment modalities have been reported for control of malignant pleural effusions.4 Repeated thoracocentesis is an ineffective means of
REFERENCES (16)
- et al.
Treatment of malignant pleural effusion.
Chest
(1985) - et al.
Carcinomatosis involvement of the pleura: an analysis of 96 patients.
Am J Med
(1977) - et al.
The treatment of recurrent malignant pleural effusion.
Ann Thorac Surg
(1979) Intrapleural tetracycline for malignant pleural effusions.
Chest
(1975)- et al.
Treatment of pleural effusion.
Chest
(1986) - et al.
The pH of sclerosing agents: a determinant of pleural symphysis.
Chest
(1979) - et al.
Intrapleural therapy with tetracycline in malignant pleural effusions.
Chest
(1978) Intrapleural therapy with tetracycline and lidocaine for malignant pleural effusions.
Chest
(1978)
Cited by (29)
Intervention in the pleura
2000, European Journal of Radiology
Manuscript received August 28; revision accepted November 25.